|
July 29th, 2026 | Wednesday
|
|
GSK plc announced plans to establish a major new global R&D centre in Cambridge, UK, as part of the company’s plan to accelerate its R&D pipeline. The new 300,000 square foot site, on the Cambridge Biomedical Campus in the heart of the UK’s life sciences “Golden Triangle,” will be home to GSK’s R&D operations in the UK and more than 1,000 GSK scientists.
The Cambridge Biomedical Campus is one of the largest biomedical campuses in Europe. The new location will provide GSK scientists with direct access to a world-class ecosystem of biomedical research, patient care and academia, enabling translational research by bridging laboratory science with clinical practice.
The GSK site will feature state-of-the-art, tech-enabled labs and infrastructure to support research in the company’s focus areas of Oncology, Respiratory, Hepatology, Vaccines and HIV.
Luke Miels, Chief Executive Officer, GSK, said: “This investment will accelerate our R&D and help us deliver new, competitive products. It integrates GSK further into one of the world’s leading centres of knowledge and demonstrates the attractiveness of the UK’s life sciences ecosystem.”
Tony Wood, Chief Scientific Officer, GSK, said: “Cambridge has built one of the world’s best life sciences ecosystems, with leading universities, hospitals and biotech companies. The campus provides exceptional opportunities for collaboration. With our existing connections and experience, we see this move as a catalyst for faster, bolder medicines discovery by accelerating the science that matters most for GSK's next wave of medicines.”
The site in Cambridge, currently in development by Prologis, will be part of GSK’s wider UK network of collaboration with leading academic institutions and pioneering scientific organisations, including the University of Oxford, Kings College London, Imperial College, the University of Manchester, Wellcome and the Crick Institute.
Read More →
|
For latest updates follow us on
|
|
|
This email has been sent to you in association with
www.biospectrumjobs.com
Tell Us What You Think! Help us improve our newsletters.
Send us your feedback!
© Copyright 2026 MM ACTIV. All rights reserved.
Disclaimer : Please remember – by opting-in you are still able to opt-out at any time, by simply replying to this email at digital@mmactiv.com and typing 'unsubscribe' in the 'subject' field of any future emails. We promise only to send emails that we believe you will find interesting, relevant and current.
Your data will never be sold or shared with any third party, although we may communicate a message to you from a partner that we are in collaboration with.
|
|
|
